We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
-11.42%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$286M
AUM Growth
-$474M
(-62%)
Cap. Flow
-$416M
Cap. Flow
% of AUM
-145.73%
Top 10 Holdings %
Top 10 Hldgs %
76.36%
Holding
35
New
4
Increased
1
Reduced
14
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$12.8M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$8.97M |
| 3 |
Alkermes
ALKS
|
+$7.31M |
| 4 |
DexCom
DXCM
|
+$4.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integer Holdings
ITGR
|
+$35.4M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$21.7M |
| 3 |
Becton Dickinson
BDX
|
+$19.3M |
| 4 |
Quest Diagnostics
DGX
|
+$19.1M |
| 5 |
Medtronic
MDT
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.64% |
| 2 | Technology | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Integer Holdings
ITGR
$4.12B
| – | – |
-740,475
| Closed | -$35.4M |
|
27
Perrigo
PRGO
$1.4B
| – | – |
-118,000
| Closed | -$17.1M |
|
28
Steris
STE
$22.3B
| – | – |
-209,169
| Closed | -$15.8M |
|
29
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-100,000
| Closed | -$6.56M |
|
30
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| – | – |
-788,300
| Closed | -$95.1M |
|
|
SRGA
31
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| – | – |
-41,667
| Closed | -$4.96M |
|
|
VAR
32
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-39,913
| Closed | -$2.83M |
|
|
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-100,000
| Closed | -$8.74M |
|
|
ALR
34
DELISTED
Alere Inc
ALR
| – | – |
-225,000
| Closed | -$8.79M |
|
|
SGNT
35
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| – | – |
-450,000
| Closed | -$7.16M |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU
Tamarack Advisers's Q1 2016 Portfolio in Review
As of Q1 2016, Tamarack Advisers held 35 positions worth $286M, down 62% from $760M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Tamarack Advisers withdrew a net $416M in Q1 2016, closing 14 positions and reducing 14 holdings. Its most notable exit was Integer Holdings, an estimated $35.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 59% a quarter earlier, followed by Technology.
Against the trend, Tamarack Advisers opened a new position in Labcorp worth $13.5M.
- Tamarack Advisers's largest Q1 2016 buy was Labcorp: 133,860 shares worth $13.5M.
- Tamarack Advisers added most to Alkermes in Q1 2016, an estimated $7.31M increase.
- Tamarack Advisers's biggest Q1 2016 reduction was Patterson Companies, Inc., cutting an estimated $21.7M.
- Tamarack Advisers fully exited Integer Holdings in Q1 2016, selling an estimated $35.4M.
- Tamarack Advisers's ten largest holdings make up 76% of its $286M portfolio in Q1 2016.
- Tamarack Advisers opened 4 new positions and closed 14 in Q1 2016.
- Tamarack Advisers's portfolio value fell 62% quarter-over-quarter to $286M.
Based on Tamarack Advisers's 13F filing for Q1 2016, filed 16 May 2016.